Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oracea Patient Centered Outcomes in Rosacea
NCT01872715Phase 4Completed
- Sponsor
- Galderma
- Start
- Mar 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in papulopustular rosacea, sponsored by Galderma. Started Mar 2013; status: completed.
02
Drugs
doxycycline
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT01872715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01872715.